Insmed





Ebitda Cambiamento Data
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Cytokinetics USD -107.82M 45.51M 2025-06
DBV Technologies USD -33.48M 5.55M 2025-09
Dynavax Technologies USD 35.53M 10.9M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -297.13M 71.11M 2025-06
Novartis USD 5.84B 235M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Insmed - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.